Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Glycopyrrolate / Formoterol bulk supplier for pharma manufacturers

Glycopyrrolate / Formoterol Suppliers & Bulk Manufacturers

Available Forms: Pressurized metered-dose inhaler (pMDI)

Available Strengths: Glycopyrrolate 9 mcg + Formoterol fumarate 4.8 mcg

Reference Brands: Bevespi Aerosphere(US)

Category: Respiratory Disorder

Glycopyrrolate + Formoterol is a LAMA/LABA combination used for COPD maintenance treatment. Marketed as Bevespi Aerosphere in the U.S., it offers twice-daily bronchodilation via a metered-dose inhaler, helping improve lung function and reduce breathlessness in COPD patients. It is not intended for acute symptom relief.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Glycopyrrolate + Formoterol is a long-acting bronchodilator combination used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). Glycopyrrolate, a LAMA, and Formoterol, a LABA, work together to relax airway muscles, improve airflow, and reduce symptoms like breathlessness. Marketed as Bevespi Aerosphere in the United States, this combination is delivered via a pressurized metered-dose inhaler (pMDI) and taken twice daily. It is not intended for acute symptom relief but provides long-term control of COPD symptoms. Bevespi Aerosphere helps enhance lung function, reduce exacerbations, and improve the overall quality of life for patients with moderate to severe COPD.

Glycopyrrolate / Formoterol — third party manufacturing & bulk supply

Glycopyrrolate / Formoterol is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Glycopyrrolate / Formoterol listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Glycopyrrolate / Formoterol →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Glycopyrrolate / Formoterol is used for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It helps improve lung function, reduce exacerbations, and relieve symptoms such as shortness of breath and wheezing.

This combination is made from glycopyrrolate (glycopyrronium bromide) and formoterol fumarate dihydrate. Glycopyrrolate is a long-acting muscarinic antagonist (LAMA) that relaxes airway muscles by blocking acetylcholine receptors, while formoterol is a long-acting beta-2 agonist (LABA) that provides bronchodilation.

Common trade names include Bevespi Aerosphere (USA), and various regional or generic brands available in global markets.

The original product is marketed by AstraZeneca. It is also manufactured by multiple pharmaceutical companies globally as inhalation combination products.

The complete generic name is glycopyrronium bromide and formoterol fumarate dihydrate.

Brand names include Bevespi Aerosphere and various region-specific generic brands.

This combination is manufactured globally in countries such as the USA, EU nations, India, and other regions by both innovator and generic pharmaceutical companies.

Related Products

Salmeterol Xinafoate

Strength:
25 µg, 50 µg

Form: Inhalation

Reference Brands: Serevent (USA/LATAM/EU)

View Details
Formoterol Fumarate

Strength:
12 µg

Form: Inhalation

Reference Brands: Foradil (USA/LATAM), Oxis (India)

View Details
Ethionamide

Strength:
250 mg

Form: Tablets

Reference Brands: Generic formulations marketed under different names

View Details
Olodaterol

Strength:
2.5 mcg

Form: Inhalation solution

Reference Brands: Striverdi Respimat (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.